These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 16876733)

  • 1. Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction.
    Hanna IR; Heeke B; Bush H; Brosius L; King-Hageman D; Dudley SC; Beshai JF; Langberg JJ
    Heart Rhythm; 2006 Aug; 3(8):881-6. PubMed ID: 16876733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-lowering drugs: beyond lowering lipid levels to their influence on cardiac arrhythmias.
    Kantharia BK
    Heart Rhythm; 2006 Aug; 3(8):887-8. PubMed ID: 16876734
    [No Abstract]   [Full Text] [Related]  

  • 3. QRS duration is associated with atrial fibrillation in patients with left ventricular dysfunction.
    El-Chami MF; Brancato C; Langberg J; Delurgio DB; Bush H; Brosius L; Leon AR
    Clin Cardiol; 2010 Mar; 33(3):132-8. PubMed ID: 20235216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of pretreatment with angiotensin-converting enzyme inhibitors with improvement in ablation outcome in atrial fibrillation patients with low left ventricular ejection fraction.
    Mohanty S; Mohanty P; Trivedi C; Gianni C; Bai R; Burkhardt JD; Gallinghouse JG; Horton R; Sanchez JE; Hranitzky PM; Al-Ahmad A; Bailey S; Di Biase L; Natale A
    Heart Rhythm; 2015 Sep; 12(9):1963-71. PubMed ID: 26051531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
    Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are we ready for a statin on our toast?
    DeSilvey DL
    Am J Geriatr Cardiol; 2006; 15(6):392-3. PubMed ID: 17086036
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction.
    Ozaydin M; Varol E; Türker Y; Peker O; Erdoğan D; Doğan A; Ibrişim E
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):137-42. PubMed ID: 20382613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of heart rate in elderly with systolic heart failure and concomitant atrial fibrillation.
    Barywani S; Petzold M
    Scand Cardiovasc J; 2017 Aug; 51(4):190-196. PubMed ID: 28393567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between stature and the prevalence of atrial fibrillation in patients with left ventricular dysfunction.
    Hanna IR; Heeke B; Bush H; Brosius L; King-Hageman D; Beshai JF; Langberg JJ
    J Am Coll Cardiol; 2006 Apr; 47(8):1683-8. PubMed ID: 16631009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation.
    Al Chekakie MO; Akar JG; Wang F; Al Muradi H; Wu J; Santucci P; Varma N; Wilber DJ
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):942-6. PubMed ID: 17593228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal heart failure therapy and successful cardioversion in heart failure patients with atrial fibrillation.
    Boldt LH; Rolf S; Huemer M; Parwani AS; Luft FC; Dietz R; Haverkamp W
    Am Heart J; 2008 May; 155(5):890-5. PubMed ID: 18440338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillation.
    Wachtell K; Devereux RB; Lyle PA
    Curr Cardiol Rep; 2006 Sep; 8(5):356-64. PubMed ID: 16956451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
    Shah R; Wang Y; Foody JM
    Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
    Savelieva I; Kakouros N; Kourliouros A; Camm AJ
    Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.
    Healey JS; Baranchuk A; Crystal E; Morillo CA; Garfinkle M; Yusuf S; Connolly SJ
    J Am Coll Cardiol; 2005 Jun; 45(11):1832-9. PubMed ID: 15936615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.
    Nieuwlaat R; Eurlings LW; Cleland JG; Cobbe SM; Vardas PE; Capucci A; López-Sendòn JL; Meeder JG; Pinto YM; Crijns HJ
    J Am Coll Cardiol; 2009 May; 53(18):1690-8. PubMed ID: 19406345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of statins and antihypertensive medications in relation to risk of long-standing persistent atrial fibrillation.
    Thacker EL; Jensen PN; Psaty BM; McKnight B; Longstreth WT; Dublin S; Newton KM; Smith NL; Siscovick DS; Heckbert SR
    Ann Pharmacother; 2015 Apr; 49(4):378-86. PubMed ID: 25628466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
    Ho SF; O'Mahony MS; Steward JA; Burr ML; Buchalter M
    Age Ageing; 2004 Sep; 33(5):488-92. PubMed ID: 15271642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protecting the heart with cardiac medication in patients with left ventricular dysfunction undergoing major noncardiac vascular surgery.
    Feringa HH; Bax JJ; Schouten O; Poldermans D
    Semin Cardiothorac Vasc Anesth; 2006 Mar; 10(1):25-31. PubMed ID: 16703231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.